301 related articles for article (PubMed ID: 18621559)
41. Transferrin receptor 2 protein is not expressed in normal erythroid cells.
Calzolari A; Deaglio S; Sposi NM; Petrucci E; Morsilli O; Gabbianelli M; Malavasi F; Peschle C; Testa U
Biochem J; 2004 Aug; 381(Pt 3):629-34. PubMed ID: 15084147
[TBL] [Abstract][Full Text] [Related]
42. Activity of the notch-signalling pathway in circulating human chronic lymphocytic leukaemia cells.
Hajdu M; Sebestyén A; Barna G; Reiniger L; Jánosi J; Sréter L; Várkonyi J; Demeter J; Kopper L
Scand J Immunol; 2007 Mar; 65(3):271-5. PubMed ID: 17309782
[TBL] [Abstract][Full Text] [Related]
43. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
44. The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells.
de Vries JF; Falkenburg JH; Willemze R; Barge RM
Haematologica; 2006 Jul; 91(7):912-9. PubMed ID: 16818278
[TBL] [Abstract][Full Text] [Related]
45. Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells.
Zheng Z; Venkatapathy S; Rao G; Harrington CA
Leukemia; 2002 Dec; 16(12):2429-37. PubMed ID: 12454749
[TBL] [Abstract][Full Text] [Related]
46. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
47. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
48. Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23.
Chen JR; Gu BJ; Dao LP; Bradley CJ; Mulligan SP; Wiley JS
Br J Haematol; 1999 Apr; 105(1):181-9. PubMed ID: 10233382
[TBL] [Abstract][Full Text] [Related]
49. Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia.
Kornblau SM; Chen N; del Giglio A; O'Brien S; Deisseroth AB
Cancer Res; 1994 Jan; 54(1):242-6. PubMed ID: 8261446
[TBL] [Abstract][Full Text] [Related]
50. Quantification of CD20 mRNA and protein levels in chronic lymphocytic leukemia suggests a post-transcriptional defect.
Sarro SM; Unruh TL; Zuccolo J; Sanyal R; Luider JM; Auer-Grzesiak IA; Mansoor A; Deans JP
Leuk Res; 2010 Dec; 34(12):1670-3. PubMed ID: 20674973
[TBL] [Abstract][Full Text] [Related]
51. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
52. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?
Caligaris-Cappio F; Ghia P
J Clin Oncol; 2008 Sep; 26(27):4497-503. PubMed ID: 18662968
[TBL] [Abstract][Full Text] [Related]
53. The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells.
Herbison CE; Thorstensen K; Chua AC; Graham RM; Leedman P; Olynyk JK; Trinder D
Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1567-75. PubMed ID: 19828835
[TBL] [Abstract][Full Text] [Related]
54. Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice.
Okazaki F; Matsunaga N; Okazaki H; Utoguchi N; Suzuki R; Maruyama K; Koyanagi S; Ohdo S
Cancer Res; 2010 Aug; 70(15):6238-46. PubMed ID: 20631077
[TBL] [Abstract][Full Text] [Related]
55. The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia.
Lotfi K; Karlsson K; Fyrberg A; Juliusson G; Jonsson V; Peterson C; Eriksson S; Albertioni F
Biochem Pharmacol; 2006 Mar; 71(6):882-90. PubMed ID: 16436271
[TBL] [Abstract][Full Text] [Related]
56. Mythylation of human HLA-D/DR genes: derangement in chronic lymphocytic leukemia.
Tobe H; Ruether BA; Jerry LM; Tamaoki T
Cancer Biochem Biophys; 1986 Oct; 8(4):313-26. PubMed ID: 3492264
[TBL] [Abstract][Full Text] [Related]
57. Chronic B-lymphocytic leukemia--expression of B cell activation markers in relation to activity of the disease.
Tötterman TH; Carlsson M; Funderud S; Simonsson B; Oberg G; Nilsson K
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):279-81. PubMed ID: 3265498
[TBL] [Abstract][Full Text] [Related]
58. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V
Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907
[TBL] [Abstract][Full Text] [Related]
59. Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia.
Eisele L; Prinz R; Klein-Hitpass L; Nückel H; Lowinski K; Thomale J; Moeller LC; Dührsen U; Dürig J
Eur J Haematol; 2009 Oct; 83(4):320-7. PubMed ID: 19500131
[TBL] [Abstract][Full Text] [Related]
60. Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cells.
Ryan EP; Pollock SJ; Kaur K; Felgar RE; Bernstein SH; Chiorazzi N; Phipps RP
Clin Immunol; 2006 Jul; 120(1):76-90. PubMed ID: 16473553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
